Veterinary Medicines

Depomycin (200 mg + 200 mg) /ml Zawiesina do wstrzykiwań

Authorised
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
Download as PDF

Product identification

Medicine name:
Depomycin (200 mg + 200 mg) /ml Zawiesina do wstrzykiwań
Active substance:
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
Target species:
  • Cattle
  • Sheep
  • Horse
  • Cat
  • Pig
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dihydrostreptomycin sulfate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        30
        day
      • Milk
        5
        day
      • Meat and offal
        56
        day
    • Sheep
      • Meat and offal
        35
        day
      • Meat and offal
        56
        day
    • Horse
      • All relevant tissues
        no withdrawal period
    • Cat
    • Pig
      • Meat and offal
        30
        day
      • Meat and offal
        49
        day
    • Dog
  • Subcutaneous use
    • Cattle
      • Meat and offal
        56
        day
      • Milk
        5
        day
      • Meat and offal
        30
        day
    • Sheep
      • Meat and offal
        56
        day
      • Meat and offal
        35
        day
    • Horse
      • All relevant tissues
        no withdrawal period
    • Cat
    • Pig
      • Meat and offal
        49
        day
      • Meat and offal
        30
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.r.l.
  • Intervet International B.V.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0339
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."